marketcaparena
Search

    CSTL

    CASTLE BIOSCIENCES INC

    Company overview

    Market capitalization
    $1.10B
    Employees
    942
    Latest publication
    2026-09-29
    About CASTLE BIOSCIENCES INC

    Castle Biosciences, Inc., a molecular diagnostics company, provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), atopic dermatitis (AD), and uveal melanoma. The company offers DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test that predicts the likelihood of a positive sentinel lymph node and the risk of metastasis for patients with invasive cutaneous melanoma; TissueCypher, a risk stratification spatialomics test to predict future development of high-grade dysplasia and/or esophageal cancer in patients with non-dysplastic, indefinite dysplasia, and low-grade dysplasia BE; AdvanceAD-Tx, a non-invasive GEP test which is designed to guide systemic treatment selection for patients aged 12 years and older with moderateto-severe AD; DecisionDx-SCC, a GEP test for cutaneous squamous cell carcinoma; and MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions. It also provides DecisionDx-UM, a risk stratification GEP test that predicts the risk of metastasis for patients with uveal melanoma. The company offers its products to dermatology and gastroenterology markets. The company was incorporated in 2007 and is headquartered in Friendswood, Texas.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USDQ2 20202020-06-30 · USDQ1 20202020-03-31 · USDQ4 20192019-12-31 · USDQ1 20192019-03-31 · USD
    Total Revenue103,546,000USD86,311,000USD85,782,000USD87,002,000USD12,715,000USD17,418,000USD17,634,553USD8,716,987USD
    Cost Of Revenue23,700,000USD16,183,000USD15,609,000USD14,519,000USD2,146,000USD2,391,000USD2,010,536USD1,597,958USD
    Gross Profit79,846,000USD70,128,000USD70,173,000USD72,483,000USD10,569,000USD15,027,000USD15,624,017USD7,119,029USD
    Research Development14,543,000USD11,677,000USD12,323,000USD14,136,000USD2,704,000USD2,913,000USD3,158,946USD1,393,851USD
    Selling General Administrative66,122,000USD19,552,000USD20,664,000USD18,413,000USD10,392,000USD11,078,000USD9,852,469USD6,046,622USD
    Other Operating Expenses2,251,000USD———————
    Total Operating Expenses82,916,000USD66,078,000USD65,094,000USD67,471,000USD11,214,000USD13,991,000USD13,011,415USD7,440,473USD
    Operating Income-3,070,000USD4,050,000USD5,079,000USD5,012,000USD-645,000USD1,036,000USD2,612,602USD-321,444USD
    Total Other Income Expense Net1,380,000USD3,835,000USD3,203,000USD2,874,000USD-731,000USD-466,000USD-485,835USD-1,035,983USD
    Interest Income2,356,000USD3,372,000USD3,404,000USD3,144,000USD38,000USD298,000USD280,492USD1,003,610USD
    Interest Expense193,000USD92,000USD201,000USD270,000USD769,000USD764,000USD765,888USD1,024,400USD
    Income Before Tax-1,690,000USD7,885,000USD8,282,000USD7,886,000USD-1,376,000USD570,000USD2,126,767USD-1,357,983USD
    Income Tax Expense370,000USD-1,705,000USD6,013,000USD-1,034,000USD38,000USD298,000USD72,000USD991,472USD
    Net Income-2,060,000USD9,590,000USD2,269,000USD8,920,000USD-1,376,000USD570,000USD2,054,767USD-1,357,983USD
    Selling And Marketing Expenses—30,413,000USD29,835,000USD32,675,000USD——469USD—
    Unclassified Operating Expenses—4,436,000USD2,272,000USD2,247,000USD-1,882,000USD———
    Net Interest Income—3,280,000USD3,203,000USD2,874,000USD-731,000USD-466,000USD-485,396USD-1,003,611USD
    Tax Provision—-1,705,000USD6,013,000USD-1,034,000USD0USD0USD72,000USD0USD
    Net Income From Continuing Ops—9,590,000USD2,269,000USD8,920,000USD-1,376,000USD570,000USD2,054,767USD-1,357,983USD
    Ebit—7,977,000USD8,483,000USD8,156,000USD-607,000USD1,334,000USD2,892,655USD-333,580USD
    Ebitda—13,745,000USD12,024,000USD11,504,000USD-505,000USD1,425,000USD2,992,176USD-253,660USD
    Depreciation And Amortization—5,768,000USD3,541,000USD3,348,000USD102,000USD91,000USD99,521USD79,920USD
    Reconciled Depreciation—5,768,000USD3,541,000USD3,348,000USD102,000USD91,000USD99,521USD79,920USD
    Net Income Applicable To Common Shares————-1,376,000USD570,000USD2,055,276USD-2,342,360USD
    Non Operating Income Net Other———————0USD
    Minority Interest———————0USD
    Discontinued Operations———————0USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20242024-12-31 · USDFY 20192019-12-31 · USD
    Total Revenue332,069,000USD51,865,000USD
    Cost Of Revenue60,205,000USD7,310,000USD
    Gross Profit271,864,000USD44,555,000USD
    Research Development52,041,000USD7,385,000USD
    Selling General Administrative76,580,000USD29,842,000USD
    Selling And Marketing Expenses123,467,000USD—
    Unclassified Operating Expenses11,106,000USD—
    Total Operating Expenses263,194,000USD37,227,000USD
    Operating Income8,670,000USD7,328,000USD
    Interest Income12,916,000USD312,000USD
    Interest Expense577,000USD4,571,000USD
    Net Interest Income12,339,000USD-4,259,000USD
    Income Before Tax21,564,000USD5,349,000USD
    Income Tax Expense3,319,000USD72,000USD
    Tax Provision3,319,000USD72,000USD
    Net Income18,245,000USD5,277,000USD
    Net Income From Continuing Ops18,245,000USD5,277,000USD
    Ebit22,141,000USD9,920,000USD
    Ebitda38,138,000USD10,278,000USD
    Depreciation And Amortization15,997,000USD358,000USD
    Reconciled Depreciation15,997,000USD358,000USD
    Total Other Income Expense Net12,894,000USD-1,979,000USD
    Net Income Applicable To Common Shares—2,991,000USD
    SourceLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets561,177,000USD547,805,000USD578,556,000USD562,786,000USD544,729,000USD501,715,000USD531,235,000USD514,565,000USD
    Cash And Equivalents62,116,000USD———————
    Cash And Short Term Investments266,805,000USD261,685,000USD299,505,000USD287,542,000USD275,930,000USD275,151,000USD293,130,000USD279,785,000USD
    Short Term Investments204,689,000USD197,921,000USD182,776,000USD201,986,000USD193,697,000USD185,462,000USD173,421,000USD184,826,000USD
    Total Current Assets341,100,000USD328,901,000USD361,097,000USD357,569,000USD348,668,000USD349,388,000USD360,154,000USD344,772,000USD
    Other Current Assets15,374,000USD14,491,000USD7,956,000USD11,895,000USD12,061,000USD11,035,000USD7,671,000USD8,154,000USD
    Other Non Current Assets4,442,000USD———————
    Total Liabilities91,147,000USD———————
    Total Current Liabilities56,509,000USD48,761,000USD68,677,000USD55,308,000USD50,890,000USD37,274,000USD49,392,000USD44,295,000USD
    Total Stockholder Equity470,030,000USD461,416,000USD470,873,000USD467,046,000USD455,376,000USD440,306,000USD455,835,000USD441,055,000USD
    Total Equity Including Noncontrolling Interest470,030,000USD———————
    Short Long Term Debt2,917,000USD1,667,000USD417,000USD—1,944,000USD1,111,000USD278,000USD—
    Long Term Debt7,158,000USD8,399,000USD9,640,000USD10,049,000USD8,096,000USD8,921,000USD9,745,000USD10,015,000USD
    Net Receivables48,341,000USD42,264,000USD43,382,000USD49,482,000USD52,311,000USD56,353,000USD51,218,000USD50,261,000USD
    Inventory10,580,000USD10,461,000USD10,254,000USD8,650,000USD8,366,000USD6,849,000USD8,135,000USD6,572,000USD
    Property Plant Equipment Net118,878,000USD115,358,000USD112,238,000USD100,036,000USD89,563,000USD66,587,000USD62,706,000USD56,287,000USD
    Accounts Payable9,668,000USD15,038,000USD18,711,000USD12,211,000USD13,181,000USD8,502,000USD6,901,000USD6,810,000USD
    Short Term Debt1,417,000USD2,921,000USD1,742,000USD1,449,000USD3,515,000USD2,546,000USD1,943,000USD1,745,000USD
    Retained Earnings-240,866,000USD-238,806,000USD-224,284,000USD-221,952,000USD-221,451,000USD-225,974,000USD-200,126,000USD-209,716,000USD
    Accumulated Other Comprehensive Income-256,000USD-63,000USD267,000USD239,999USD39,000USD131,000USD230,000USD473,000USD
    Intangible Assets—86,647,000USD88,882,000USD91,158,000USD93,433,000USD67,212,000USD95,537,000USD99,869,000USD
    Total Liab—86,389,000USD107,683,000USD95,740,000USD89,353,000USD61,409,000USD75,400,000USD73,510,000USD
    Other Current Liab—30,802,000USD48,224,000USD41,648,000USD33,001,000USD24,946,000USD39,472,000USD35,740,000USD
    Common Stock—30,000USD30,000USD29,000USD29,000USD29,000USD28,000USD28,000USD
    Capital Stock—30,000USD30,000USD29,000USD29,000USD29,000USD28,000USD28,000USD
    Good Will—10,700,000USD10,692,000USD10,691,000USD10,692,000USD10,692,000USD10,692,000USD10,700,000USD
    Cash—63,764,000USD116,729,000USD85,556,000USD82,233,000USD89,689,000USD119,709,000USD94,959,000USD
    Net Debt—-27,040,000USD-79,816,000USD-48,417,000USD-44,881,000USD-63,845,000USD-93,365,000USD-68,219,000USD
    Short Long Term Debt Total—36,724,000USD36,913,000USD37,139,000USD37,352,000USD25,844,000USD26,344,000USD26,740,000USD
    Property Plant Equipment Gross—135,222,000USD130,535,000USD116,875,000USD105,078,000USD80,807,000USD75,539,000USD67,762,000USD
    Common Stock Shares Outstanding—29,889,000shares29,333,000shares29,073,000shares29,545,000shares28,609,000shares30,200,000shares29,401,000shares
    Non Current Assets Total—218,904,000USD217,459,000USD205,217,000USD196,061,000USD152,327,000USD171,081,000USD169,793,000USD
    Non Current Liabilities Total—37,628,000USD39,006,000USD40,432,000USD38,463,000USD24,135,000USD26,008,000USD29,215,000USD
    Non Current Liabilities Other—1,500,000USD1,500,000USD1,500,000USD1,500,000USD———
    Non Currrent Assets Other—6,199,000USD5,647,000USD3,332,000USD2,373,000USD2,266,000USD2,146,000USD2,937,000USD
    Net Working Capital—280,140,000USD292,420,000USD302,261,000USD297,778,000USD312,114,000USD310,762,000USD300,477,000USD
    Unclassified Current Liabilities—-1,667,000USD——————
    Unclassified Non Current Liabilities—27,729,000USD27,866,000USD28,883,000USD28,867,000USD15,214,000USD16,263,000USD19,200,000USD
    Unclassified Equity—700,225,000USD694,830,000USD688,700,001USD676,730,000USD666,091,000USD655,675,000USD650,242,000USD
    Long Term Investments—————5,570,000USD——
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets578,556,000USD531,235,000USD453,340,000USD447,329,000USD462,572,000USD439,328,000USD119,746,000USD22,404,935USD
    Intangible Assets88,882,000USD95,537,000USD106,643,000USD115,656,000USD88,922,000USD——4,167USD
    Other Current Assets7,956,000USD7,671,000USD6,292,000USD6,207,000USD9,614,000USD4,766,000USD1,951,000USD675,000USD
    Total Liab107,683,000USD75,400,000USD62,071,000USD48,179,000USD50,832,000USD23,637,000USD34,633,000USD32,474,086USD
    Total Stockholder Equity470,873,000USD455,835,000USD391,269,000USD399,150,000USD411,740,000USD415,691,000USD85,113,000USD-10,069,151USD
    Other Current Liab48,224,000USD39,472,000USD36,262,000USD29,583,000USD20,466,000USD11,887,000USD7,512,000USD5,277,415USD
    Common Stock30,000USD28,000USD27,000USD27,000USD25,000USD25,000USD17,000USD1,916USD
    Capital Stock30,000USD28,000USD27,000USD27,000USD25,000USD25,000USD17,000USD46,498,067USD
    Retained Earnings-224,284,000USD-200,126,000USD-218,371,000USD-160,905,000USD-93,767,000USD-62,496,000USD-52,212,000USD-57,488,578USD
    Good Will10,692,000USD10,692,000USD10,692,000USD10,692,000USD0USD——0USD
    Cash116,729,000USD119,709,000USD98,841,000USD122,948,000USD329,633,000USD409,852,000USD98,845,000USD4,478,512USD
    Cash And Short Term Investments299,505,000USD293,130,000USD243,099,000USD258,625,000USD329,633,000USD409,852,000USD98,845,000USD4,478,512USD
    Total Current Assets361,097,000USD360,154,000USD295,635,000USD292,288,000USD353,743,000USD429,594,000USD116,681,000USD18,126,026USD
    Total Current Liabilities68,677,000USD49,392,000USD47,667,000USD36,128,000USD24,886,000USD20,876,000USD15,289,000USD6,737,021USD
    Net Debt-79,816,000USD-93,365,000USD-83,506,000USD-109,548,000USD-321,430,000USD-409,852,000USD-73,723,000USD20,021,240USD
    Short Term Debt1,742,000USD1,943,000USD1,137,000USD1,777,000USD1,179,000USD5,833,000USD5,833,000USD0USD
    Short Long Term Debt417,000USD278,000USD————5,833,000USD0USD
    Short Long Term Debt Total36,913,000USD26,344,000USD15,335,000USD13,400,000USD8,203,000USD—25,122,000USD24,499,752USD
    Long Term Debt9,640,000USD9,745,000USD————19,289,000USD24,499,752USD
    Short Term Investments182,776,000USD173,421,000USD144,258,000USD135,677,000USD0USD——0USD
    Net Receivables43,382,000USD51,218,000USD38,302,000USD23,476,000USD17,282,000USD12,759,000USD14,648,000USD12,090,000USD
    Inventory10,254,000USD8,135,000USD7,942,000USD3,980,000USD2,021,000USD2,217,000USD1,237,000USD882,233USD
    Accounts Payable18,711,000USD6,901,000USD10,268,000USD4,731,000USD2,546,000USD2,098,000USD1,865,000USD1,451,000USD
    Property Plant Equipment Net112,238,000USD62,706,000USD37,739,000USD26,496,000USD16,884,000USD7,102,000USD2,060,000USD1,528,996USD
    Property Plant Equipment Gross130,535,000USD75,539,000USD45,850,000USD26,496,000USD16,884,000USD7,102,000USD2,060,000USD1,528,996USD
    Accumulated Other Comprehensive Income267,000USD230,000USD136,000USD-381,000USD—0USD-119,746,000USD-909,385USD
    Common Stock Shares Outstanding28,986,000shares29,255,000shares26,802,000shares26,054,000shares25,137,000shares18,929,000shares8,658,000shares10,650,405shares
    Non Current Assets Total217,459,000USD171,081,000USD157,705,000USD155,041,000USD108,829,000USD9,734,000USD3,065,000USD4,278,909USD
    Non Current Liabilities Total39,006,000USD26,008,000USD14,404,000USD12,051,000USD25,946,000USD2,761,000USD19,344,000USD25,737,065USD
    Non Current Liabilities Other1,500,000USD——90,000USD18,411,000USD1,026,000USD—0USD
    Non Currrent Assets Other5,647,000USD2,146,000USD2,631,000USD2,197,000USD1,715,000USD2,632,000USD1,005,000USD2,745,746USD
    Net Working Capital292,420,000USD310,762,000USD247,968,000USD256,160,000USD328,857,000USD408,718,000USD101,392,000USD11,389,005USD
    Unclassified Non Current Liabilities27,866,000USD16,263,000USD14,404,000USD11,533,000USD-11,511,000USD-1,026,000USD——
    Unclassified Equity694,830,000USD655,675,000USD609,450,000USD560,382,000USD505,457,000USD478,137,000USD257,037,000USD1,828,829USD
    Other Liab———428,000USD19,046,000USD2,761,000USD55,000USD1,238,000USD
    Other Assets———2,197,000USD3,023,000USD2,632,000USD1,005,000USD2,746,000USD
    Net Tangible Assets———272,802,000USD322,818,000USD415,691,000USD85,113,000USD-56,570,000USD
    Unclassified Non Current Assets———-2,197,000USD-1,715,000USD-2,632,000USD-1,005,000USD-2,746,000USD
    Unclassified Current Assets————-4,807,000USD———
    Current Deferred Revenue—————6,615,000USD——
    Unclassified Current Liabilities—————-5,557,000USD-5,754,000USD—
    Deferred Long Term Liab———————91,000USD
    Long Term Investments———————0USD
    Accumulated Depreciation———————0USD
    Additional Paid In Capital———————0USD
    Treasury Stock———————0USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-14,522,000USD-2,332,000USD-501,000USD4,523,000USD-25,848,000USD9,590,000USD2,269,000USD8,920,000USD
    Depreciation3,929,000USD3,777,000USD3,816,000USD3,414,000USD29,764,000USD5,768,000USD3,541,000USD3,348,000USD
    Stock Based Compensation9,776,000USD11,406,000USD12,100,000USD11,208,000USD11,179,000USD11,439,000USD13,027,000USD13,179,000USD
    Other Non Cash Items-1,944,000USD1,018,000USD-4,403,000USD-2,167,000USD20,000USD-2,108,000USD-1,525,000USD-1,819,000USD
    Change To Account Receivables1,075,000USD6,272,000USD1,911,000USD3,910,000USD-5,217,000USD-769,000USD-4,254,000USD-3,358,000USD
    Change To Inventory-207,000USD-1,604,000USD-307,000USD-1,517,000USD1,286,000USD-1,563,000USD1,441,000USD-368,000USD
    Change In Working Capital-19,358,000USD13,969,000USD11,503,000USD8,510,000USD-20,381,000USD1,983,000USD776,000USD1,912,000USD
    Total Cash From Operating Activities-22,129,000USD26,931,000USD22,631,000USD20,821,000USD-6,036,000USD24,365,000USD23,338,000USD23,998,000USD
    Capital Expenditures-12,455,000USD-7,184,000USD-14,834,000USD-9,263,000USD-4,740,000USD-7,567,000USD-6,378,000USD-5,229,000USD
    Free Cash Flow-34,584,000USD19,747,000USD7,797,000USD11,558,000USD-10,776,000USD16,798,000USD16,960,000USD18,769,000USD
    Investments-13,355,000USD23,694,000USD-18,389,000USD-28,378,000USD-22,431,000USD5,770,000USD-14,789,000USD-21,417,000USD
    Total Cashflows From Investing Activities-25,803,000USD8,831,000USD-18,389,000USD-28,378,000USD-22,431,000USD5,770,000USD-14,789,000USD-21,417,000USD
    Net Borrowings-24,000USD-27,000USD-31,000USD159,000USD-26,000USD-26,000USD-24,000USD—
    Total Cash From Financing Activities-5,033,000USD-4,589,000USD-919,000USD101,000USD-1,553,000USD-5,385,000USD838,000USD42,000USD
    Change In Cash-52,965,000USD31,173,000USD3,323,000USD-7,456,000USD-30,020,000USD24,750,000USD9,387,000USD2,623,000USD
    Begin Period Cash Flow116,729,000USD85,556,000USD82,233,000USD89,689,000USD119,709,000USD94,959,000USD85,572,000USD82,949,000USD
    End Period Cash Flow63,764,000USD116,729,000USD85,556,000USD82,233,000USD89,689,000USD119,709,000USD94,959,000USD85,572,000USD
    Other Cashflows From Investing Activities7,000USD-2,109,000USD19,000USD12,000USD-5,560,000USD7,000USD4,000USD2,000USD
    Other Cashflows From Financing Activities-5,331,000USD-6,654,000USD-965,000USD139,000USD-1,545,000USD-5,732,000USD862,000USD53,000USD
    Unclassified Investing Cash Flow—-5,570,000USD14,815,000USD9,251,000USD10,300,000USD7,560,000USD6,374,000USD5,227,000USD
    Unclassified Financing Cash Flow—2,092,000USD————-1,089,000USD—
    Unclassified Operating Cash Flow———-4,667,000USD—-2,307,000USD5,250,000USD-1,542,000USD
    Sale Purchase Of Stock——————1,089,000USD-615,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-24,158,000USD18,245,000USD-57,466,000USD-67,138,000USD-31,292,000USD-10,284,000USD5,277,000USD-6,366,994USD
    Depreciation40,771,000USD15,997,000USD12,330,000USD10,543,000USD3,407,000USD472,000USD358,000USD323,016USD
    Stock Based Compensation45,893,000USD50,320,000USD51,219,000USD36,321,000USD21,740,000USD8,309,000USD1,249,000USD293,639USD
    Other Non Cash Items-5,532,000USD-6,972,000USD-4,856,000USD-19,497,000USD33,040,000USD2,220,000USD2,367,000USD542,373USD
    Change To Account Receivables6,876,000USD-12,643,000USD-14,930,000USD-6,218,000USD-4,631,000USD1,663,000USD-896,000USD-8,407,626USD
    Change To Inventory-2,142,000USD-193,000USD-3,962,000USD-1,680,000USD327,000USD-980,000USD-355,000USD-577,657USD
    Change In Working Capital13,601,000USD-14,125,000USD-6,630,000USD-7,000USD-4,102,000USD9,148,000USD44,000USD-7,358,962USD
    Total Cash From Operating Activities64,347,000USD64,866,000USD-5,626,000USD-41,655,000USD-18,983,000USD9,865,000USD7,015,000USD-12,294,511USD
    Capital Expenditures-36,021,000USD-28,326,000USD-13,621,000USD-5,632,000USD-3,483,000USD-4,751,000USD-937,000USD-277,036USD
    Free Cash Flow28,326,000USD36,540,000USD-19,247,000USD-47,287,000USD-22,466,000USD5,114,000USD6,078,000USD-12,571,547USD
    Investments2,019,000USD-50,137,000USD-12,993,000USD-166,545,000USD-66,657,000USD-4,748,000USD-937,000USD-277,036USD
    Total Cashflows From Investing Activities-60,367,000USD-50,137,000USD-16,183,000USD-166,545,000USD-66,657,000USD-4,748,000USD-937,000USD-277,036USD
    Net Borrowings75,000USD9,903,000USD-142,000USD-122,000USD-8,000USD-27,359,000USD20,916,000USD5,418,000USD
    Total Cash From Financing Activities-6,960,000USD6,139,000USD-2,298,000USD1,515,000USD5,421,000USD305,890,000USD88,288,000USD15,837,996USD
    Change In Cash-2,980,000USD20,868,000USD-24,107,000USD-206,685,000USD-80,219,000USD311,007,000USD94,366,000USD3,266,449USD
    Begin Period Cash Flow119,709,000USD98,841,000USD122,948,000USD329,633,000USD409,852,000USD98,845,000USD4,479,000USD1,212,063USD
    End Period Cash Flow116,729,000USD119,709,000USD98,841,000USD122,948,000USD329,633,000USD409,852,000USD98,845,000USD4,478,512USD
    Other Cashflows From Investing Activities-7,638,000USD18,000USD13,000USD742,000USD10,000USD3,000USD—0USD
    Other Cashflows From Financing Activities-9,051,000USD-5,781,000USD-2,156,000USD1,637,000USD5,429,000USD3,208,000USD1,441,000USD10,383,000USD
    Unclassified Operating Cash Flow-6,228,000USD1,401,000USD—-1,877,000USD-41,776,000USD—-2,280,000USD—
    Unclassified Investing Cash Flow-18,727,000USD28,308,000USD10,418,000USD4,890,000USD3,473,000USD4,748,000USD——
    Unclassified Financing Cash Flow2,016,000USD2,017,000USD5,134,000USD3,376,000USD3,898,000USD—-1,223,000USD-10,383,204USD
    Sale Purchase Of Stock——-5,134,000USD-1,688,000USD-781,000USD—67,154,000USD10,420,200USD
    Change To Liabilities———582,000USD-182,000USD169,000USD557,000USD197,000USD
    Dividends Paid———-1,688,000USD-3,117,000USD——0USD
    Issuance Of Capital Stock————250,537,000USD330,041,000USD65,980,000USD10,382,507USD
    Exchange Rate Changes———————0USD
    Cash And Cash Equivalents Changes———————0USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30ProductDermatologic48,704,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductNon Dermatologic54,842,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31ProductDermatologic41,105,000USD0001628280-26-031263
    Q1 2026Quarterly · 2026-03-31ProductNon Dermatologic42,574,000USD0001628280-26-031263
    Q4 2025Quarterly · 2025-12-31ProductDermatologic48,587,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductNon Dermatologic38,423,000USDLegacy provider
    FY 2025Yearly · 2025-12-31ProductDermatologic216,369,000USD0001628280-26-012272
    FY 2025Yearly · 2025-12-31ProductNon Dermatologic127,860,000USD0001628280-26-012272
    Q3 2025Quarterly · 2025-09-30ProductDermatologic48,523,000USD0001628280-25-048254
    Q3 2025Quarterly · 2025-09-30ProductNon Dermatologic34,520,000USD0001628280-25-048254
    Q2 2025Quarterly · 2025-06-30ProductDermatologic56,297,000USD0001447362-25-000097
    Q2 2025Quarterly · 2025-06-30ProductNon Dermatologic29,891,000USD0001447362-25-000097
    Q1 2025Quarterly · 2025-03-31ProductDermatologic62,962,000USD0001628280-26-031263
    Q1 2025Quarterly · 2025-03-31ProductNon Dermatologic25,026,000USD0001628280-26-031263
    Q4 2024Quarterly · 2024-12-31ProductDermatologic63,774,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductNon Dermatologic22,537,000USDLegacy provider
    FY 2024Yearly · 2024-12-31ProductDermatologic256,996,000USD0001628280-26-012272
    FY 2024Yearly · 2024-12-31ProductNon Dermatologic75,073,000USD0001628280-26-012272
    Q3 2024Quarterly · 2024-09-30ProductDermatologic65,060,000USD0001628280-25-048254
    Q3 2024Quarterly · 2024-09-30ProductNon Dermatologic20,722,000USD0001628280-25-048254
    FY 2023Yearly · 2023-12-31ProductDermatologic183,375,000USD0001628280-26-012272
    FY 2023Yearly · 2023-12-31ProductNon Dermatologic36,413,000USD0001628280-26-012272
    FY 2022Yearly · 2022-12-31ProductDermatologic124,809,000USD0001447362-25-000031
    FY 2022Yearly · 2022-12-31ProductNon Dermatologic12,230,000USD0001447362-25-000031
    FY 2021Yearly · 2021-12-31ProductDermatologic85,753,000USD0001447362-23-000038
    FY 2021Yearly · 2021-12-31ProductService Other8,332,000USD0001447362-23-000038
    FY 2020Yearly · 2020-12-31ProductDermatologic57,646,000USD0001447362-22-000045
    FY 2020Yearly · 2020-12-31ProductService Other5,003,000USD0001447362-22-000045

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.